Cargando…

The effect of reduced RDI of chemotherapy on the outcome of breast cancer patients

The aims of this study were to investigate the impact of the relative dose intensity (RDI) of chemotherapy on disease-free survival (DFS) and overall survival (OS), to identify the optimal RDI cut-off points with the docetaxel, epirubicin and cyclophosphamide (TEC) regimen for stage I–III breast can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Wanwan, Wang, Xiaoyi, Gan, Lu, Li, Yunhai, Li, Hongyuan, Cheng, Qiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413525/ https://www.ncbi.nlm.nih.gov/pubmed/32764734 http://dx.doi.org/10.1038/s41598-020-70187-8

Ejemplares similares

RDI Calculator: An Analysis Tool to Assess RNA Distributions in Cells
por: Stueland, Michael, et al.
Publicado: (2019)

Lessons for science and technology policy? Probing the Linkedin network of an RDI organisation
por: Sachini, Evi, et al.
Publicado: (2022)

Vitamin K2 Needs an RDI Separate from Vitamin K1
por: Akbulut, Asim Cengiz, et al.
Publicado: (2020)

CHD4 in the DNA-damage response and cell cycle progression: not so NuRDy now
por: O’Shaughnessy, Aoife, et al.
Publicado: (2013)

Crx(Rdy) Cat: A Large Animal Model for CRX-Associated Leber Congenital Amaurosis
por: Occelli, Laurence M., et al.
Publicado: (2016)

Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Li, Yunhai, et al.
Publicado: (2021)

Business as usual? Assessing the impact of the COVID-19 pandemic to research, development and innovation (RDI) activities of universities of applied sciences
por: Salomaa, Maria, et al.
Publicado: (2021)

Can large-scale RDI funding stimulate post-crisis recovery growth? Evidence for Finland during COVID-19
por: Mitze, Timo, et al.
Publicado: (2023)

Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma
por: Terada, Yoshiki, et al.
Publicado: (2009)

Main complications and results of treatment with intra-arterial infusion chemotherapy through the subclavian and thoracic arteries for locally advanced breast cancer
por: WANG, XIAOYI, et al.
Publicado: (2013)

The Effects of Preoperative Volume Replacement in Diabetic Patients Undergoing Coronary Artery Bypass Grafting Surgery: Protocol for a Randomized Controlled Trial (VeRDiCT Trial)
por: Clout, Madeleine, et al.
Publicado: (2017)

Integrating expert opinions with clinical trial data to analyse low-powered subgroup analyses: a Bayesian analysis of the VeRDiCT trial
por: Thirard, Russell, et al.
Publicado: (2020)

Clinicopathological Characteristics and Breast Cancer–Specific Survival of Patients With Single Hormone Receptor–Positive Breast Cancer
por: Li, Yunhai, et al.
Publicado: (2020)

Efficacy and safety of neoadjuvant chemotherapy regimens for triple-negative breast cancer: a network meta-analysis
por: Li, Yunhai, et al.
Publicado: (2019)

Weight Gain during Neoadjuvant Chemotherapy is Associated with Worse Outcome among the Patients with Operable Breast Cancer
por: Fang, Qiong, et al.
Publicado: (2019)

Circular RNA 0001073 Attenuates Malignant Biological Behaviours in Breast Cancer Cell and Is Delivered by Nanoparticles to Inhibit Mice Tumour Growth
por: Yi, Ziying, et al.
Publicado: (2020)

Evaluating the Effectiveness of Neoadjuvant Chemotherapy in Reducing Mastectomy for Women With Breast Cancer
por: Mohiuddin, Jahan J., et al.
Publicado: (2017)

Chemotherapy-induced prospective memory impairment in breast cancer patients with different hormone receptor expression
por: Li, Wen, et al.
Publicado: (2017)

Outcome after neoadjuvant chemotherapy in Asian breast cancer patients
por: Lim, Li Yan, et al.
Publicado: (2016)

Triple-negative breast cancer outcomes: Does AJCC 8th staging improve chemotherapy decision-making
por: Lian, Chen-Lu, et al.
Publicado: (2021)

Effects of core needle biopsy and subsequent neoadjuvant chemotherapy on molecular alterations and outcome in breast cancer
por: Xie, Lingmin, et al.
Publicado: (2018)

Clinicopathological characteristics and survival outcomes in patients with angiosarcoma of breast
por: Li, Junfeng, et al.
Publicado: (2023)

Breast Cancer-Derived Microparticles Reduce Cancer Cell Adhesion, an Effect Augmented by Chemotherapy
por: Shechter, Dvir, et al.
Publicado: (2020)

Effect of adjuvant chemotherapy on the survival outcomes of elderly breast cancer: A retrospective cohort study based on SEER database
por: Wu, Yunhao, et al.
Publicado: (2022)

Altered network efficiency of functional brain networks in patients with breast cancer after chemotherapy
por: Xuan, Han, et al.
Publicado: (2017)

Implication from thyroid function decreasing during chemotherapy in breast cancer patients: chemosensitization role of triiodothyronine
por: Huang, Jianbo, et al.
Publicado: (2013)

How Does the Interval Between Completion of Adjuvant Chemotherapy and Initiation of Radiotherapy Impact Clinical Outcomes in Operable Breast Cancer Patients?
por: Cao, Lu, et al.
Publicado: (2020)

Reduced MCPH1 expression in breast cancer and response to chemotherapy
por: Richardson, J, et al.
Publicado: (2010)

Impact of Neoadjuvant Chemotherapy on Immediate Breast Reconstruction: A Meta-Analysis
por: Song, Junlong, et al.
Publicado: (2014)

Effects of Chemotherapy on Serum Lipids in Chinese Postoperative Breast Cancer Patients
por: Lu, Qi, et al.
Publicado: (2020)

Effect and safety of bevacizumab-containing chemotherapy treatment in Chinese patients with metastatic colorectal cancer
por: Wu, Qian, et al.
Publicado: (2013)

Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo
por: Jia, Deyong, et al.
Publicado: (2015)

Correlation of UGT2B7 Polymorphism with Cardiotoxicity in Breast Cancer Patients Undergoing Epirubicin/Cyclophosphamide-Docetaxel Adjuvant Chemotherapy
por: Li, Hai, et al.
Publicado: (2019)

Effect of neoadjuvant chemotherapy on the expression of hormone receptors and Ki67 in Chinese breast cancer patients: A retrospective study of 525 patients
por: Wu, Yu-tuan, et al.
Publicado: (2018)

Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel-based chemotherapy in breast cancer patients
por: Chen, Lu, et al.
Publicado: (2018)

Chemotherapy of advanced breast cancer: outcome and prognostic factors.
por: Gregory, W. M., et al.
Publicado: (1993)

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy
por: Straver, M. E., et al.
Publicado: (2010)

Outcomes of children exposed in utero to chemotherapy for breast cancer
por: Murthy, Rashmi K, et al.
Publicado: (2014)

Current Research Status of Metronomic Chemotherapy in Combination Treatment of Breast Cancer
por: Liu, Jiaxuan, et al.
Publicado: (2022)

Clinicopathological risk factors for recurrence after neoadjuvant chemotherapy and radical hysterectomy in cervical cancer
por: Wang, Huali, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pjqela7apk2don3b3grcan04lf